- Filed
- Mar 26, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 21, 2025 | 426.2M sh |
| Short Term Debt | Q1 2025 · Feb 28, 2025 | $0 |
| Short Term Debt | Q1 2025 · Nov 29, 2024 | $1.5B |
| Short Term Investments | Q1 2025 · Feb 28, 2025 | $677M |
| Short Term Investments | Q1 2025 · Nov 29, 2024 | $273M |
| Cash And Equivalents | Q1 2025 · Feb 28, 2025 | $6.76B |
| Cash And Equivalents | Q1 2025 · Nov 29, 2024 | $7.61B |
| Current Liabilities | Q1 2025 · Feb 28, 2025 | $9.16B |
| Current Liabilities | Q1 2025 · Nov 29, 2024 | $10.52B |
| Total Liabilities | Q1 2025 · Feb 28, 2025 | $16.86B |
| Total Liabilities | Q1 2025 · Nov 29, 2024 | $16.13B |
| Current Assets | Q1 2025 · Feb 28, 2025 | $10.86B |
| Current Assets | Q1 2025 · Nov 29, 2024 | $11.23B |
| Total Assets | Q1 2025 · Feb 28, 2025 | $29.96B |
| Total Assets | Q1 2025 · Nov 29, 2024 | $30.23B |
| Shares Diluted | Q1 2025 · Mar 1, 2024 | 456.3M sh |
| Stock Repurchased | Q1 2025 · Mar 1, 2024 | $2B |
| Capex | Q1 2025 · Mar 1, 2024 | $37M |
| Operating Cash Flow | Q1 2025 · Mar 1, 2024 | $1.17B |
| Stockholders Equity | Q1 2025 · Mar 1, 2024 | $15.46B |
| Stockholders Equity | Q1 2025 · Dec 1, 2023 | $16.52B |
| Eps Diluted | Q1 2025 · Mar 1, 2024 | $1.36 |
| Eps Basic | Q1 2025 · Mar 1, 2024 | $1.37 |
| Sga Expense | Q1 2025 · Mar 1, 2024 | $352M |
| Net Income | Q1 2025 · Mar 1, 2024 | $620M |
| Operating Income | Q1 2025 · Mar 1, 2024 | $907M |
| Gross Profit | Q1 2025 · Mar 1, 2024 | $4.59B |
| Cost Of Revenue | Q1 2025 · Mar 1, 2024 | $590M |
| Revenue | Q1 2025 · Mar 1, 2024 | $5.18B |